Vidaza 25 mg/mL powder for suspension for injection.
Powder for suspension for injection.
White lyophilised powder.
Each vial contains 100 mg azacitidine. After reconstitution, each mL of suspension contains 25 mg azacitidine.
For the full list of excipients, see section 6.1.
Colourless type I glass vial sealed with butyl elastomeric stopper and aluminium seal with polypropylene plastic button, containing 100 mg of azacitidine.
Pack size: 1 vial.
Celgene Europe B.V., Winthontlaan 6 N, 3526 KV Utrecht, Netherlands
Date of first authorisation: 17 December 2008
Date of latest renewal: 13 November 2013